Geneviève Baron

Geneviève Baron

Auto-generated profile, based on publicly available information

Geneviève Baron

Direction de Santé Publique du CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada; Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, QC, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2019 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
MGMaryse Guay
Maryse Guay
VGVirginie Gosselin
Virginie Gosselin
GPGeneviève Petit
Geneviève Petit
GBGeneviève Baron
Geneviève Baron
AGArnaud Gagneur
Arnaud Gagneur
Objectives: Vaccine hesitancy is a global phenomenon that needs to be measured and addressed. This study aimed to identify the determinants of vaccine hesitancy among a large regional population. Methods: A structured telephone survey was administered to a random digit sample in Quebec’s Eastern Townships region. In addition to socioeconomic information, respondents were asked questions on several health topics such as knowledge and beliefs about immunization, medical consultations, health status, and life habits. Data were weighted according to age, sex, and territories. Statistically significant variables in the univariate analysis were introduced into a multivariate logistic regression model to determine independent factors for vaccine hesitancy (adjusted odds ratios [aOR] and 95% confidence intervals). Results: A total of 8,737 interviews were conducted (participation rate 48.3%). Among all respondents, 32.2% were vaccine-hesitant. Several beliefs were significantly associated with vaccine hesitancy: belief that children receive too many vaccines (aOR = 2.72; 2.32–3.18), belief that a healthy lifestyle can eliminate the need for vaccination (aOR = 2.48; 2.09–2.93), and belief that the use of alternative medicine practices can eliminate the need for vaccination (aOR = 1.39; 1.16–1.68). Other determinants associated with vaccine hesitancy were having consulted a massage therapist (aOR = 2.34; 1.46–3.75), not being vaccinated against influenza (aOR = 1.80; 1.49–2.16), having a low (<$30,000) (aOR = 1.58; 1.24–2.02) or moderate ($30,000–$79,000) (aOR = 1.37; 1.12–1.67) household income, distrust in public health authorities (aOR = 1.40; 1.21–1.63), perceived insufficient knowledge about immunization (aOR = 1.26; 1.04–1.51), and smoking (aOR = 1.22; 1.01–1.47). Conclusions: Many determinants are related to vaccine hesitancy. These determinants should be taken into account when health professionals engage with vaccine-hesitant individuals.

19 November 2022 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
CBCatherine Bouchard
Catherine Bouchard
ADAriane Dumas
Ariane Dumas
GBGeneviève Baron
Geneviève Baron
NBNatasha Bowser
Natasha Bowser
PLPatrick A. Leighton
Patrick A. Leighton
CACécile Aenishaenslin
Cécile Aenishaenslin
Lyme disease (LD) risk is emerging rapidly in Canada due to range expansion of its tick vectors, accelerated by climate change. The risk of contracting LD varies geographically due to variability in ecological characteristics that determine the hazard (the densities of infected host-seeking ticks) and vulnerability of the human population determined by their knowledge and adoption of preventive behaviors. Risk maps are commonly used to support public health decision-making on Lyme disease, but the ability of the human public to adopt preventive be-haviors is rarely taken into account in their development, which represents a critical gap. The objective of this work was to improve LD risk mapping using an integrated social-behavioral and ecological approach to: (i) compute enhanced integrated risk maps for prioritization of interventions and (ii) develop a spatially-explicit assessment tool to examine the relative contribution of different risk factors.The study was carried out in the Estrie region located in southern Que acute accent bec. The blacklegged tick, Ixodes scapularis, infected with the agent of LD is widespread in Estrie and as a result, regional LD incidence is the highest in the province. LD knowledge and behaviors in the population were measured in a cross-sectional health survey conducted in 2018 reaching 10,790 respondents in Estrie. These data were used to create an index for the social-behavioral component of risk in 2018. Local Empirical Bayes estimator technique were used to better quantify the spatial variance in the levels of adoption of LD preventive activities. For the ecological risk analysis, a tick abundance model was developed by integrating data from ongoing long-term tick surveillance programs from 2007 up to 2018. Social-behavioral and ecological components of the risk measures were combined to create vulnerability index maps and, with the addition of human population densities, prioritization index maps. Map predictions were validated by testing the association of high-risk areas with the current spatial distribution of human cases of LD and reported tick exposure. Our results demonstrated that social-behavioral and ecological components of LD risk have markedly different distributions within Estrie. The occurrence of human LD cases or reported tick exposure in a municipality was positively associated with tick density and the prioritization risk index (p < 0.001).This research is a second step towards a more comprehensive integrated LD risk assessment approach, examining social-behavioral risk factors that interact with ecological risk factors to influence the management of emerging tick-borne diseases, an approach that could be applied more widely to vector-borne and zoonotic diseases.

5 June 2019 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
AGArnaud Gagneur
Arnaud Gagneur
VGVirginie Gosselin
Virginie Gosselin
JBJulie Bergeron
Julie Bergeron
AFAnne Farrands
Anne Farrands
GBGeneviève Baron
Geneviève Baron
Objective: Vaccine hesitancy is a complex problem. We previously demonstrated that motivational interviewing (MI) could be helpful to enhance parents’ motivation to vaccinate their child. The aim of this study is to develop a new, simple and robust evaluation tool that is suitable for evaluating MI learning of vaccination health professionals. Methods: We designed the Motivational Interviewing Skills in Immunization (MISI), a short written questionnaire to evaluate the MI knowledge and skills of participants in an immunization context. It covers three key areas: knowledge of MI, ability to apply MI-related skills, participant self-confidence in using MI. Questionnaire content and face validity were assessed by MI experts and internal consistency, reliability and effect size were analyzed using a multiple pretest-posttest design. Results: Psychometric measures showed good to excellent internal consistency of the questionnaire for all three areas (Cronbach’s and KR coefficient: 0.70 to 0.88). Test-retest reliability showed good measurement stability (ICC: 0.53). Good sensitivity to change was also obtained (Cohen’s d: 0.80 to 1.66). Conclusion: The MISI questionnaire is the first paper/pencil evaluation method to assess MI training specific to immunization. Psychometric measures showed high reliability. Practice implications: This questionnaire could provide a convenient and inexpensive method to evaluate knowledge and competencies following immunization-specific MI training.

15 October 2015 in Der Unfallchirurg
Verified
Journal Article
Closed access
PDF file
FJFranz Jakob
Franz Jakob
FGFranca Genest
Franca Genest
GBG. Baron
G. Baron
USU. Stumpf
U. Stumpf
Maximilian RudertMaximilian Rudert
Maximilian Rudert
LSLothar Seefried
Lothar Seefried

21 October 2023 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
NBNatasha Bowser
Natasha Bowser
CBCatherine Bouchard
Catherine Bouchard
MCMiguel Sautié Castellanos
Miguel Sautié Castellanos
GBGeneviève Baron
Geneviève Baron
HCHélène Carabin
Hélène Carabin
CACécile Aenishaenslin
Cécile Aenishaenslin
Background: Lyme disease (LD) and other tick-borne diseases are emerging across Canada. Spatial and temporal LD risk is typically estimated using acarological surveillance and reported human cases, the former not considering human behavior leading to tick exposure and the latter occurring after infection.Objectives: The primary objective was to explore, at the census subdivision level (CSD), the associations of selfreported tick exposure, alternative risk indicators (predicted tick density, eTick submissions, public health risk level), and ecological variables (Ixodes scapularis habitat suitability index and cumulative degree days > 0 C) with incidence proportion of LD. A secondary objective was to explore which of these predictor variables were associated with self-reported tick exposure at the CSD level.Methods: Self-reported tick exposure was measured in a cross-sectional populational health survey conducted in 2018, among 10,790 respondents living in 116 CSDs of the Estrie region, Quebec, Canada. The number of reported LD cases per CSD in 2018 was obtained from the public health department. Generalized linear mixedeffets models accounting for spatial autocorrelation were built to fulfill the objectives.Results: Self-reported tick exposure ranged from 0.0 % to 61.5 % (median 8.9 %) and reported LD incidence rates ranged from 0 to 324 cases per 100,000 person-years, per CSD. A positive association was found between selfreported tick exposure and LD incidence proportion (ss = 0.08, CI = 0.04,0.11, p < 0.0001). The best-fit model included public health risk level (AIC: 144.2), followed by predicted tick density, ecological variables, self-reported tick exposure and eTick submissions (AIC: 158.4, 158.4, 160.4 and 170.1 respectively). Predicted tick density was the only significant predictor of self-reported tick exposure (ss = 0.83, CI = 0.16,1.50, p = 0.02).Discussion: This proof-of-concept study explores self-reported tick exposure as a potential indicator of LD risk using populational survey data. This approach may offer a low-cost and simple tool for evaluating LD risk and deserves further evaluation.

14 March 2025 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
JPJérôme Pelletier
Jérôme Pelletier
JRJean-Philippe Rocheleau
Jean-Philippe Rocheleau
CBCatherine Bouchard
Catherine Bouchard
GBGeneviève Baron
Geneviève Baron
HCHeather Coatsworth
Heather Coatsworth
CACécile Aenishaenslin
Cécile Aenishaenslin
Lyme disease (LD) is a threat to public health in southern regions of Canada. In response, we used a One Health approach to design an integrated intervention in a high-incidence LD community in southern Québec aiming to increase preventive behaviours in the population and reduce the density of Borrelia burgdorferi-infected Ixodes scapularis ticks in the environment. The environmental component involved distributing fluralaner baits to rodents around residential properties and public trails from 2019 to 2023. Effectiveness was measured by changes in the density of questing nymphs (DON) and the prevalence of B. burgdorferi-infected nymphs (NIP). Treated areas were compared to areas located between 0 and 250 m from treatment locations and to untreated areas located >250 m away. The DON was reduced by 39 % (95 % confidence interval [95 % CI] = 1 - 62 %) in treated areas when compared to untreated areas in 2021 and 2022. Over this same period, in areas between 0 and 250 m, the DON was lower when closer to bait stations (P = 0.001). The treatment significantly reduced the NIP in treated area in 2020 (Odds ratio [OR] = 0.87 [95 % CI 0.08 - 0.98]), 2021 (OR = 0.85 [95 % CI 0.26 - 0.97], and 2022 (OR = 0.88 [95 % CI 0.12 - 0.98]), and in areas between 0 and 250 m in 2020 (OR = 0.87 [0.08 - 0.98]) and 2021 (OR = 0.84 [95 % CI 0.25 - 0.97]). This study confirms the potential of rodent-targeted fluralaner baiting for reducing the density of infected questing nymphs in peri‑urban environments.